CryoPort Shares Rise After Q3 Revenue Beat, 2026 Guidance Raise

MT Newswires Live11-07

CryoPort (CYRX) shares rose 19% on Friday, a day after the company posted higher-than-expected Q3 revenue and raised its 2026 guidance.

The company reported a Q3 loss late Thursday of $0.25 per diluted share, widening from a loss of $0.18 a year earlier.

Analysts polled by FactSet expected a loss of $0.18.

Revenue for the three months ended Sept. 30 was $50.2 million, up from $44.2 million a year earlier.

Analysts expected $48.7 million.

For full-year 2026, the company now expects revenue of $197 million to $199 million. It earlier expected revenue of $192 million to $196 million.

Analysts expect $197.8 million.

Price: 19.13, Change: +3.08, Percent Change: +19.19

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment